STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

PRAH PRA HEALTH SCIENCES StockScouter® Report

9

StockScouter® Score

PRA HEALTH SCIENCES, a mid cap growth company in the healthcare sector, is expected to outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The enterprise value-to-sales ratio is lower than the average for comparably-sized companies in the StockScouter universe. Positive
  • The multi-period measure of relative price change and consistency is above average. Positive/Neutral
  • One or more less experienced analysts has modestly increased quarterly earnings estimates for PRAH. Positive/Neutral

 

Concerns

  • Short-term relative price momentum exhibits moderate weakness. Neutral/Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 100% done.
Low
High

Core Model Grades

A
C
B
B

Previous Ratings

7
9
6